Circulating renalase, catecholamines, and vascular adhesion protein 1 in hypertensive patients.

J Am Soc Hypertens 2015 Nov 12;9(11):855-64. Epub 2015 Aug 12.

Second Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland.

The aim of the study was to estimate and correlate circulating levels of renalase, vascular adhesion protein-1 (VAP-1), catecholamines in patients with primary hypertension. The renalase, VAP-1, and catecholamines concentration was estimated in 121 hypertensive patients. The correlation between renalase, VAP-1 levels and catecholamine concentration in blood, blood pressure control, pharmacological therapy, and medical history were taken in to consideration. The median office blood pressure was 145.5/86 mm Hg and was significantly higher than the median home blood pressure measurement value, which was 135/80 mm Hg, P < .05. Circulating renalase and VAP-1 (Me 9.57 μg/mL and Me = 326.7 ng/mL) levels were significantly higher in patients with hypertension comparing to healthy individuals (3.83 μg/mL and 248.37 ng/mL, P < .05). The correlation between renalase and noradrenalin concentration in blood was observed (r = 0.549; P < .05), also the correlation between VAP-1 and noradrenaline was noticed (r = 0.21, P = .029). Renalase level was higher in patients with coronary artery disease and correlated with decreased ejection fraction. VAP-1 concentration correlated also with left ventricular ejection fraction (r = -0.23, P = .013). Hypertensive patients with diabetes mellitus had almost statistically significant higher VAP-1 concentration compared with hypertensive patients without diabetes mellitus (Me = 403.22 ng/mL vs. Me = 326,68 ng/mL, P = .064). In multiple regression analysis, renalase was predicted by plasma dopamine and norepinephrine as also diastolic office blood pressure and left ventricle ejection fraction. Circulating renalase and VAP-1 levels are elevated in patients with poor blood pressure control. Its correlation with noradrenalin concentration need further studies to find out the role of renalase as also VAP-1 in pathogenesis and treatment of hypertension.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jash.2015.08.002DOI Listing
November 2015
8 Reads

Publication Analysis

Top Keywords

blood pressure
12
hypertensive patients
8
renalase vap-1
8
vap-1 catecholamines
8
blood blood
4
levels catecholamine
4
catecholamine concentration
4
vap-1 levels
4
blood
4
concentration blood
4
patients correlation
4
hypertension renalase
4
primary hypertension
4
catecholamines concentration
4
estimated 121
4
121 hypertensive
4
correlation renalase
4
control pharmacological
4
higher median
4
1455/86 mm higher
4

Similar Publications